These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 8275492

  • 1. Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy.
    Husain I, Mohler JL, Seigler HF, Besterman JM.
    Cancer Res; 1994 Jan 15; 54(2):539-46. PubMed ID: 8275492
    [Abstract] [Full Text] [Related]

  • 2. Immunological quantitation of levels of tissue inhibitor of metalloproteinase-1 in human colon cancer.
    Lu XQ, Levy M, Weinstein IB, Santella RM.
    Cancer Res; 1991 Dec 01; 51(23 Pt 1):6231-5. PubMed ID: 1933883
    [Abstract] [Full Text] [Related]

  • 3. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
    Campbell-Thompson M, Lynch IJ, Bhardwaj B.
    Cancer Res; 2001 Jan 15; 61(2):632-40. PubMed ID: 11212261
    [Abstract] [Full Text] [Related]

  • 4. Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma.
    Murnane MJ, Sheahan K, Ozdemirli M, Shuja S.
    Cancer Res; 1991 Feb 15; 51(4):1137-42. PubMed ID: 1997157
    [Abstract] [Full Text] [Related]

  • 5. Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan.
    Liebes L, Potmesil M, Kim T, Pease D, Buckley M, Fry D, Cho J, Adler H, Dar K, Zeleniuch-Jacquotte A, Hochster H.
    Clin Cancer Res; 1998 Mar 15; 4(3):545-57. PubMed ID: 9533521
    [Abstract] [Full Text] [Related]

  • 6. Gastric and hepatocellular carcinomas do not overexpress the same ribosomal protein messenger RNAs as colonic carcinoma.
    Barnard GF, Staniunas RJ, Mori M, Puder M, Jessup MJ, Steele GD, Chen LB.
    Cancer Res; 1993 Sep 01; 53(17):4048-52. PubMed ID: 8395335
    [Abstract] [Full Text] [Related]

  • 7. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
    Goldwasser F, Bae I, Fornace AJ, Pommier Y.
    Oncol Res; 1996 Sep 01; 8(7-8):317-23. PubMed ID: 8938795
    [Abstract] [Full Text] [Related]

  • 8. Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma.
    Levy AT, Cioce V, Sobel ME, Garbisa S, Grigioni WF, Liotta LA, Stetler-Stevenson WG.
    Cancer Res; 1991 Jan 01; 51(1):439-44. PubMed ID: 1846313
    [Abstract] [Full Text] [Related]

  • 9. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia.
    Berggren M, Gallegos A, Gasdaska JR, Gasdaska PY, Warneke J, Powis G.
    Anticancer Res; 1996 Jan 01; 16(6B):3459-66. PubMed ID: 9042207
    [Abstract] [Full Text] [Related]

  • 10. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score.
    Sinha AA, Quast BJ, Korkowski JC, Wilson MJ, Reddy PK, Ewing SL, Sloane BF, Gleason DF.
    Anticancer Res; 1999 Jan 01; 19(4B):2821-9. PubMed ID: 10652560
    [Abstract] [Full Text] [Related]

  • 11. Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections.
    Tahara H, Yasui W, Tahara E, Fujimoto J, Ito K, Tamai K, Nakayama J, Ishikawa F, Tahara E, Ide T.
    Oncogene; 1999 Feb 25; 18(8):1561-7. PubMed ID: 10102626
    [Abstract] [Full Text] [Related]

  • 12. Two COOH-terminal truncated cytoplasmic forms of topoisomerase II alpha in a VP-16-selected lung cancer cell line result from partial gene deletion and alternative splicing.
    Yu Q, Mirski SE, Sparks KE, Cole SP.
    Biochemistry; 1997 May 13; 36(19):5868-77. PubMed ID: 9153428
    [Abstract] [Full Text] [Related]

  • 13. A PCR-aided transcript titration assay (PATTY) to measure topoisomerase I gene expression in human tumor specimens.
    Meersma GJ, Bakker M, Groen HJ, Van der Zee AG, Jensen PB, Giaccone G, De Vries EG, Smit EF.
    Anticancer Res; 1999 May 13; 19(2A):1309-15. PubMed ID: 10368692
    [Abstract] [Full Text] [Related]

  • 14. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
    Foster KW, Frost AR, McKie-Bell P, Lin CY, Engler JA, Grizzle WE, Ruppert JM.
    Cancer Res; 2000 Nov 15; 60(22):6488-95. PubMed ID: 11103818
    [Abstract] [Full Text] [Related]

  • 15. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
    Engelhardt M, Albanell J, Drullinsky P, Han W, Guillem J, Scher HI, Reuter V, Moore MA.
    Clin Cancer Res; 1997 Oct 15; 3(10):1849-57. PubMed ID: 9815573
    [Abstract] [Full Text] [Related]

  • 16. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines.
    Erisman MD, Scott JK, Watt RA, Astrin SM.
    Oncogene; 1988 Apr 15; 2(4):367-78. PubMed ID: 3283655
    [Abstract] [Full Text] [Related]

  • 17. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
    Nesterova M, Noguchi K, Park YG, Lee YN, Cho-Chung YS.
    Clin Cancer Res; 2000 Sep 15; 6(9):3434-41. PubMed ID: 10999726
    [Abstract] [Full Text] [Related]

  • 18. Quantitative and qualitative aspects of topoisomerase I and II alpha and beta in untreated and platinum/cyclophosphamide treated malignant ovarian tumors.
    van der Zee AG, de Jong S, Keith WN, Hollema H, Boonstra H, de Vries EG.
    Cancer Res; 1994 Feb 01; 54(3):749-55. PubMed ID: 8306337
    [Abstract] [Full Text] [Related]

  • 19. The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p.
    Banham AH, Beasley N, Campo E, Fernandez PL, Fidler C, Gatter K, Jones M, Mason DY, Prime JE, Trougouboff P, Wood K, Cordell JL.
    Cancer Res; 2001 Dec 15; 61(24):8820-9. PubMed ID: 11751404
    [Abstract] [Full Text] [Related]

  • 20. Expression and relationship between topoisomerase I and II alpha genes in tumor and normal tissues in esophageal, gastric and colon cancers.
    Kim R, Ohi Y, Inoue H, Toge T.
    Anticancer Res; 1999 Dec 15; 19(6B):5393-8. PubMed ID: 10697567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.